Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of R- +)-.alpha.-(2,3-dimethoxyphenyl-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol for the treatment of sleep disorders

Use of R- +)-.alpha.-(2,3-dimethoxyphenyl-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol for the treatment of sleep disorders

US Patent 6277864 · Granted Aug 21, 2001

Estimated economic value: $4,253,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists2012
Benzo-1,4-diazepin-2-one derivatives as phosphodiesterase PDE2 inhibitors, prepa2008
Use of (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4- piperidinemeth2006
Use of (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4- piperidinemeth2006
Use of R (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemet2005
Use of R (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemet2005
Use of R (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemet2005
Use of R(+) -&agr;-(2,3-Dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piper idi2003
Use of R(+) -&agr;-(2,3-Dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piper idi2003
Use of R(+) -&agr;-(2,3-Dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piper idi2003
Screening methods for altering circadian rhythms and for human casein kinase I &2003
Use of (+)-&agr;-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidine2002